The presence of dmins has been observed in patients with myelodysplastic syndrome, acute myelogenous leukemia or chronic myelomonocytic leukemia, and amplification of the MYC and MLL genes is observed in almost all cases (Huh et al., 2016). This evidence concerns the gene KMT2A and chronic myelomonocytic leukemia.